Cowealth Medical Holding Co., Ltd.

As of June 30, 2026, Cowealth Medical Holding Co., Ltd. carries a market capitalization of 943.64M, placing it among publicly traded companies globally. Its enterprise value stands at 3.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Cowealth Medical Holding Co., Ltd. has 66.22M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.37, and the price-to-book ratio stands at 0.35.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.34 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.89B versus a market cap of 943.64M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Cowealth Medical Holding Co., Ltd. maintains a current ratio of 2.50, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 27.67, indicating elevated leverage, while an interest coverage ratio of -11.16 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Cowealth Medical Holding Co., Ltd. posted a negative return on equity (ROE) of -9.63, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.59, reflecting losses generated across the asset base. The company generates approximately 10.94M in revenue per employee across its workforce of 265.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.27 indicates how many times Cowealth Medical Holding Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Cowealth Medical Holding Co., Ltd. recorded 50.58M in income tax expense. The company reported a pretax loss of -297.88M and -248.33M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Cowealth Medical Holding Co., Ltd.'s stock has declined approximately 27.24% over the past 52 weeks. The 50-day moving average sits at 11.90, while the 200-day moving average is 16.71.

Over the twelve months ended June 30, 2026, Cowealth Medical Holding Co., Ltd. generated 2.90B in revenue and converted that into -248.33M in net income, yielding earnings per share of -4.59. EBITDA reached -247.70M, while operating income came in at -160.54M.

As of June 30, 2026, Cowealth Medical Holding Co., Ltd. holds 636.46M in cash and equivalents against 1.36B in total debt, resulting in a net debt position of 766.84M. Total book value stands at 2.70B, with working capital of 3.33B providing operational flexibility.

Cowealth Medical Holding Co., Ltd. produced -559.04M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -11.29M in capital expenditures, free cash flow totaled -570.33M - equivalent to -7.52 per share.

Over the twelve months ended June 30, 2026, Cowealth Medical Holding Co., Ltd. posted a gross margin of 14.02, reflecting its pricing power and cost economics. The operating margin of -5.54 and net profit margin of -8.56 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -52.76: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 22.20, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cowealth Medical Holding Co., Ltd. shareholders.

Cowealth Medical Holding Co., Ltd.'s most recent stock split took place on July 16, 2020 with a 20:21 split ratio.

As of June 30, 2026, Cowealth Medical Holding Co., Ltd. has an Altman Z-Score of 1.18, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.